Insider trades
Christopher Bunka, Director of Lexaria Bioscience LEXX, has filed 2 purchases and 0 sales on the open market. The latest trade was on 03/17.
Christopher Bunka
Director
- Company
- Lexaria Bioscience LEXX
- First filing
- 23/10/30
- Trades
- 7 trades
- Buys / sales
- 2 / 0
- 12-month net buying
- No record
- Last trade
- 03/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
LEXX | Open-market buy | 25/07/29–25/07/30 | 25/07/30 | 27,500 sh2 trades | $0.92avg. | $25,181 | +10.8% |